文献速递临床试验与 GCP医学人工智能与信息学

电磁导航系统用于胸腹部CT引导介入放射操作对比常规CT引导的临床获益评估(CTNAV II):随机对照试验研究方案

Evaluation of the clinical benefit of an electromagnetic navigation system for CT-guided interventional radiology procedures in the thoraco-abdominal region compared with conventional CT guidance (CTNAV II): study protocol for a randomised controlled trial.
PubMed 文献 · Trials · 2017-07-06

本研究为开放、多中心、前瞻性、随机对照试验,计划纳入最多500例患者,比较电磁导航辅助与常规CT引导下胸腹部经皮穿刺操作的安全性和有效性。主要结局为盲法放射科医生评估的安全、疗效与性能复合指标,次要结局包括操作时长、操作者满意度、辐射剂量、亚组分析和设备可用性。

要点

  • 开放、多中心、前瞻性、随机对照试验,计划纳入最多500例患者。
  • 主要结局为盲法评估的安全、疗效与性能复合指标,不一致时由专家委员会确认。
  • 次要结局包括操作时长、操作者满意度、辐射剂量、亚组分析和设备可用性。

核心结论

  • 本试验针对导航辅助CT引导介入操作缺乏已发表的高级别证据这一问题开展研究。
  • 该试验重要,因其针对常规CT引导存在的问题,且介入放射操作在常规临床实践中数量不断增加。

研究设计与样本

  • 研究设计为开放、多中心、前瞻性、随机对照干预性临床试验,采用标准两臂平行设计、个体随机化。
  • 计划纳入最多500例患者,随机化按中心和操作的预期难度分层。
  • 试验组采用导航系统辅助操作,活性对照组采用常规CT引导操作。

主要发现

  • 主要结局为复合指标,由盲法放射科医生评估导航辅助CT引导操作的安全性(严重不良事件数量)、疗效(到达靶点数量)和性能(控制扫描次数),不一致时由专家委员会确认。
  • 次要结局为操作时长、操作者满意度、辐射剂量、按操作预期难度进行的亚组分析以及设备可用性评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Interventional radiology includes a range of minimally invasive image-guided diagnostic and therapeutic procedures that have become routine clinical practice. Each procedure involves a percutaneous needle insertion, often guided using computed tomography (CT) because of its availability and usability. However, procedures remain complicated, in particular when an obstacle must be avoided, meaning that an oblique trajectory is required. Navigation systems track the operator's instruments, meaning the position and progression of the instruments are visualised in real time on the patient's images. A novel electromagnetic navigation system for CT-guided interventional procedures (IMACTIS-CT®) has been developed, and a previous clinical trial demonstrated improved needle placement accuracy in navigation-assisted procedures. In the present trial, we are evaluating the clinical benefit of the navigation system during the needle insertion step of CT-guided procedures in the thoraco-abdominal region. METHODS/DESIGN: This study is designed as an open, multicentre, prospective, randomised, controlled interventional clinical trial and is structured as a standard two-arm, parallel-design, individually randomised trial. A maximum of 500 patients will be enrolled. In the experimental arm (navigation system), the procedures are carried out using navigation assistance, and in the active comparator arm (CT), the procedures are carried out with conventional CT guidance. The randomisation is stratified by centre and by the expected difficulty of the procedure. The primary outcome of the trial is a combined criterion to assess the safety (number of serious adverse events), efficacy (number of targets reached) and performance (number of control scans acquired) of navigation-assisted, CT-guided procedures as evaluated by a blinded radiologist and confirmed by an expert committee in case of discordance. The secondary outcomes are (1) the duration of the procedure, (2) the satisfaction of the operator and (3) the irradiation dose delivered, with (4) subgroup analysis according to the expected difficulty of the procedure, as well as an evaluation of (5) the usability of the device. DISCUSSION: This trial addresses the lack of published high-level evidence studies in which navigation-assisted CT-guided interventional procedures are evaluated. This trial is important because it addresses the problems associated with conventional CT guidance and is particularly relevant because the number of interventional radiology procedures carried out in routine clinical practice is increasing. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01896219 . Registered on 5 July 2013.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Rouchy RC, Moreau-Gaudry A, Chipon E, et al. Evaluation of the clinical benefit of an electromagnetic navigation system for CT-guided interventional radiology procedures in the thoraco-abdominal region compared with conventional CT guidance (CTNAV II): study protocol for a randomised controlled trial. Trials. 2017. PMID: 28683837. doi:10.1186/s13063-017-2049-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。